These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34729701)

  • 81. A New Ferulic Acid-Nicotinamide Cocrystal With Improved Solubility and Dissolution Performance.
    Chaves Júnior JV; Dos Santos JAB; Lins TB; de Araújo Batista RS; de Lima Neto SA; de Santana Oliveira A; Nogueira FHA; Gomes APB; de Sousa DP; de Souza FS; Aragão CFS
    J Pharm Sci; 2020 Mar; 109(3):1330-1337. PubMed ID: 31821823
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
    Newman A; Reutzel-Edens SM; Zografi G
    J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
    Hattori Y; Sato M; Otsuka M
    J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein.
    Pi J; Wang S; Li W; Kebebe D; Zhang Y; Zhang B; Qi D; Guo P; Li N; Liu Z
    Asian J Pharm Sci; 2019 Mar; 14(2):154-164. PubMed ID: 32104447
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Emodin-nicotinamide (1:2) cocrystal identified by thermal screening to improve emodin solubility.
    Park B; Yoon W; Yun J; Ban E; Yun H; Kim A
    Int J Pharm; 2019 Feb; 557():26-35. PubMed ID: 30572078
    [TBL] [Abstract][Full Text] [Related]  

  • 87. An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state.
    Lin HL; Zhang GC; Huang YT; Lin SY
    J Pharm Sci; 2014 Aug; 103(8):2386-95. PubMed ID: 24942554
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Explaining dissolution properties of rivaroxaban cocrystals.
    Hriňová E; Skořepová E; Čerňa I; Královičová J; Kozlík P; Křížek T; Roušarová J; Ryšánek P; Šíma M; Slanař O; Šoóš M
    Int J Pharm; 2022 Jun; 622():121854. PubMed ID: 35623488
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Investigation of possible solubility and dissolution advantages of cocrystals, I: Aqueous solubility and dissolution rates of ketoconazole and its cocrystals as functions of pH.
    Vasoya JM; Shah AV; Serajuddin ATM
    ADMET DMPK; 2019; 7(2):106-130. PubMed ID: 35350544
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation.
    Machado TC; Kuminek G; Cardoso SG; Rodríguez-Hornedo N
    Eur J Pharm Sci; 2020 Sep; 152():105422. PubMed ID: 32531350
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of 1α,25-dihydroxyvitamin D3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells.
    Maeng HJ; Chapy H; Zaman S; Pang KS
    Eur J Pharm Sci; 2012 Jun; 46(3):149-66. PubMed ID: 22387228
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics.
    Cheney ML; Weyna DR; Shan N; Hanna M; Wojtas L; Zaworotko MJ
    J Pharm Sci; 2011 Jun; 100(6):2172-81. PubMed ID: 21491441
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chitosan-telmisartan polymeric cocrystals for improving oral absorption: In vitro and in vivo evaluation.
    Ganesh M; Ubaidulla U; Rathnam G; Jang HT
    Int J Biol Macromol; 2019 Jun; 131():879-885. PubMed ID: 30905757
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems.
    Singh M; Barua H; Jyothi VGSS; Dhondale MR; Nambiar AG; Agrawal AK; Kumar P; Shastri NR; Kumar D
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111646
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A strategy to improve the oral availability of baicalein: The baicalein-theophylline cocrystal.
    Li W; Pi J; Zhang Y; Ma X; Zhang B; Wang S; Qi D; Li N; Guo P; Liu Z
    Fitoterapia; 2018 Sep; 129():85-93. PubMed ID: 29936192
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 97. An
    Mendis NP; Lakerveld R
    Mol Pharm; 2023 Nov; 20(11):5486-5499. PubMed ID: 37882573
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Fabrication of Carbamazepine Cocrystals: Characterization,
    Wasim M; Mannan A; Asad MHHB; Amirzada MI; Shafique M; Hussain I
    Biomed Res Int; 2021; 2021():6685806. PubMed ID: 33816628
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Co-crystallization with nicotinamide in two conformations lowers energy but expands volume.
    Zhang SW; Kendrick J; Leusen FJJ; Yu L
    J Pharm Sci; 2014 Sep; 103(9):2896-2903. PubMed ID: 24633957
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Identification and Pharmaceutical Characterization of a New Itraconazole Terephthalic Acid Cocrystal.
    Machado Cruz R; Boleslavská T; Beránek J; Tieger E; Twamley B; Santos-Martinez MJ; Dammer O; Tajber L
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32781726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.